Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
NDC 0406-8020, Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate, tablet, from SpecGx LLC.
- Product NDC
- 0406-8020
- Status
- Listed
- Labeler
- SpecGx LLC
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207000
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/0406-8020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0406-8020-03 | 00406802003 | 30 TABLET in 1 BOTTLE, PLASTIC (0406-8020-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/62abde41-46cb-4e90-a798-23d6531bf9aaNADAC price for package 00406802003
GET /v1/drugs/nadac/00406802003
Use it
Look up 0406-8020 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0406-8020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0406-8020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.